These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 29676043)

  • 1. Mitral valve interventions in heart failure.
    Lavall D; Hagendorff A; Schirmer SH; Böhm M; Borger MA; Laufs U
    ESC Heart Fail; 2018 Aug; 5(4):552-561. PubMed ID: 29676043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial.
    McCarthy PM; Whisenant B; Asgar AW; Ailawadi G; Hermiller J; Williams M; Morse A; Rinaldi M; Grayburn P; Thomas JD; Martin R; Asch FM; Shu Y; Sundareswaran K; Moat N; Kar S
    J Am Heart Assoc; 2023 Feb; 12(4):e027504. PubMed ID: 36752231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Treatment of Functional Mitral Regurgitation in Patients with Heart Failure: The COAPT Trial.
    Sodhi N; Lim DS
    Interv Cardiol Clin; 2020 Oct; 9(4):451-459. PubMed ID: 32921369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter edge-to-edge mitral valve repair in heart failure.
    Orban M; Orban M; Braun D; Nabauer M; Massberg S; Hausleiter J
    Minerva Cardioangiol; 2017 Jun; 65(3):314-320. PubMed ID: 27958694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of rehospitalization after percutaneous edge-to-edge mitral valve repair by MitraClip implantation.
    Keßler M; Seeger J; Muche R; Wöhrle J; Rottbauer W; Markovic S
    Eur J Heart Fail; 2019 Feb; 21(2):182-192. PubMed ID: 30178493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in patient selection and devices for transcatheter edge-to-edge mitral valve repair in heart failure.
    Orban M; Lüsebrink E; Braun D; Stocker TJ; Bagaev E; Hagl C; Näbauer M; Massberg S; Orban M; Hausleiter J
    Expert Rev Med Devices; 2020 Feb; 17(2):93-102. PubMed ID: 31923376
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcatheter edge-to-edge repair for secondary mitral regurgitation with third-generation devices in heart failure patients - results from the Global EXPAND Post-Market study.
    Orban M; Rottbauer W; Williams M; Mahoney P; von Bardeleben RS; Price MJ; Grasso C; Lurz P; Zamorano JL; Asch FM; Maisano F; Kar S; Hausleiter J
    Eur J Heart Fail; 2023 Mar; 25(3):411-421. PubMed ID: 36597850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair.
    Lim DS; Reynolds MR; Feldman T; Kar S; Herrmann HC; Wang A; Whitlow PL; Gray WA; Grayburn P; Mack MJ; Glower DD
    J Am Coll Cardiol; 2014 Jul; 64(2):182-92. PubMed ID: 24184254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Mitral Regurgitation and Heart Failure: Current Advances in Diagnosis and Management.
    Gerçek M; Narang A; Puthumana JJ; Davidson CJ; Rudolph V
    Heart Fail Clin; 2023 Jul; 19(3):307-315. PubMed ID: 37230646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of the transcatheter mitral valve repair for patients with severe mitral regurgitation and endangered heart failure.
    Lee CW; Huang WM; Tsai YL; Lu DY; Sung SH; Yu WC; Guo CY; Chen CH
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):452-459. PubMed ID: 32620461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of transcatheter mitral valve repair therapies - From surgical concepts towards future directions.
    Nielsen SL
    Scand Cardiovasc J; 2016; 50(5-6):367-376. PubMed ID: 27733069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for long-term survival after transcatheter edge-to-edge mitral valve repair.
    Orban M; Orban M; Lesevic H; Braun D; Deseive S; Sonne C; Hutterer L; Grebmer C; Khandoga A; Pache J; Mehilli J; Schunkert H; Kastrati A; Hagl C; Bauer A; Massberg S; Boekstegers P; Nabauer M; Ott I; Hausleiter J
    J Interv Cardiol; 2017 Jun; 30(3):226-233. PubMed ID: 28370526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter Mitral Valve Repair in Patients with Heart Failure: A Meta-Analysis.
    Vallakati A; Hasan AK; Boudoulas KD
    Cardiology; 2021; 146(1):42-48. PubMed ID: 33260194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for Secondary Mitral Regurgitation in Patients With Heart Failure: A Network Meta-Analysis of Randomized Controlled Comparisons of Surgery, Medical Therapy and Transcatheter Intervention.
    Kheiri B; Zayed Y; Barbarawi M; Osman M; Chahine A; Ahmed S; Bachuwa G; Hassan M; Alkhouli M; Feldman T; Bhatt DL
    Cardiovasc Revasc Med; 2020 Feb; 21(2):155-163. PubMed ID: 31201060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
    Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
    Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Mitral Valve Replacement in Patients With Previous Aortic Valve Replacement.
    Cheung A; Webb J; Schaefer U; Moss R; Deuschl FG; Conradi L; Denti P; Latib A; Kiaii B; Bagur R; Ferrari E; Moccetti M; Biasco L; Blanke P; Ben-Gal Y; Banai S
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e006412. PubMed ID: 30354628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.
    Muller DWM; Sorajja P; Duncan A; Bethea B; Dahle G; Grayburn P; Babaliaros V; Guerrero M; Thourani VH; Bedogni F; Denti P; Dumonteil N; Modine T; Jansz P; Chuang ML; Blanke P; Leipsic J; Badhwar V
    J Am Coll Cardiol; 2021 Nov; 78(19):1847-1859. PubMed ID: 34736561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.
    Ailawadi G; Lim DS; Mack MJ; Trento A; Kar S; Grayburn PA; Glower DD; Wang A; Foster E; Qasim A; Weissman NJ; Ellis J; Crosson L; Fan F; Kron IL; Pearson PJ; Feldman T;
    Circulation; 2019 Jan; 139(1):37-47. PubMed ID: 30586701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: The HighLife TSMVR Feasibility Study.
    Schneider LM; Worthley S; Nickenig G; Huczek Z; Wojakowski W; Tchetche D; Dubois C; Nasr M; Verhees L; Rothman M; Piazza N; Buithieu J; Yeow WL; Keßler M; Rottbauer W
    JACC Cardiovasc Interv; 2023 Dec; 16(23):2854-2865. PubMed ID: 37999708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Mack MJ; Abraham WT; Lindenfeld J; Bolling SF; Feldman TE; Grayburn PA; Kapadia SR; McCarthy PM; Lim DS; Udelson JE; Zile MR; Gammie JS; Gillinov AM; Glower DD; Heimansohn DA; Suri RM; Ellis JT; Shu Y; Kar S; Weissman NJ; Stone GW
    Am Heart J; 2018 Nov; 205():1-11. PubMed ID: 30134187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.